WO2003071986A3 - Method for treating otic disorders - Google Patents
Method for treating otic disorders Download PDFInfo
- Publication number
- WO2003071986A3 WO2003071986A3 PCT/US2003/005519 US0305519W WO03071986A3 WO 2003071986 A3 WO2003071986 A3 WO 2003071986A3 US 0305519 W US0305519 W US 0305519W WO 03071986 A3 WO03071986 A3 WO 03071986A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ear
- otic disorders
- treating otic
- inner ear
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003216379A AU2003216379A1 (en) | 2002-02-22 | 2003-02-24 | Method for treating otic disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35883102P | 2002-02-22 | 2002-02-22 | |
US60/358831 | 2002-02-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003071986A2 WO2003071986A2 (en) | 2003-09-04 |
WO2003071986A3 true WO2003071986A3 (en) | 2003-12-18 |
Family
ID=27766002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/005519 WO2003071986A2 (en) | 2002-02-22 | 2003-02-24 | Method for treating otic disorders |
Country Status (3)
Country | Link |
---|---|
US (2) | US20030229333A1 (en) |
AU (1) | AU2003216379A1 (en) |
WO (1) | WO2003071986A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9132087B2 (en) | 2008-04-21 | 2015-09-15 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
US9205048B2 (en) | 2008-07-21 | 2015-12-08 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
US9427472B2 (en) | 2008-07-21 | 2016-08-30 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
US9486405B2 (en) | 2013-08-27 | 2016-11-08 | Otonomy, Inc. | Methods for the treatment of pediatric otic disorders |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1631259A4 (en) * | 2002-12-18 | 2006-08-02 | Hough Ear Inst | Otologic nanotechnology |
US8246974B2 (en) | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
EP1633320A2 (en) | 2003-05-02 | 2006-03-15 | SurModics, Inc. | Implantable controlled release bioactive agent delivery device |
JP2008512383A (en) * | 2004-09-03 | 2008-04-24 | ピードモント ファーマシューティカルズ エルエルシー | Method for transmembrane treatment and prevention of otitis media |
WO2007044700A2 (en) * | 2005-10-07 | 2007-04-19 | Board Of Trustees Of Southern Illinois University | Protectant combinations for reducing toxicities |
US20070219272A1 (en) * | 2006-02-06 | 2007-09-20 | Johan Stjernschantz | Novel method and compositions for treatment of tinnitus |
WO2009006390A2 (en) * | 2007-07-03 | 2009-01-08 | Charles Stark Draper Laboratory, Inc. | Drug-eluting staples prosthesis |
WO2009009156A2 (en) * | 2007-07-06 | 2009-01-15 | Laclede, Inc. | Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages |
US20110046156A1 (en) | 2008-03-05 | 2011-02-24 | Miller Guy M | Treatment of hearing and balance impairments with redox-active therapeutics |
FR2930140B1 (en) * | 2008-04-17 | 2011-04-22 | Philippe Perovitch | DEVICE FOR STORING, EXTENDED PREPARATION AND ADMINISTRATION OF A LOW ASSAY OF ACTIVE INGREDIENT |
GB2459910B (en) * | 2008-04-21 | 2010-03-31 | Otonomy Inc | Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
WO2009139924A2 (en) * | 2008-05-14 | 2009-11-19 | Otonomy, Inc. | Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
US8648119B2 (en) | 2008-05-23 | 2014-02-11 | Otonomy, Inc. | Controlled release immunomodulator compositions and methods for the treatment of otic disorders |
US8846770B2 (en) | 2008-06-18 | 2014-09-30 | Otonomy, Inc. | Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders |
US9161904B2 (en) | 2008-06-26 | 2015-10-20 | Nobelpharma Co., Ltd. | Agent for regenerating tympanic membrane or external auditory canal |
WO2010011466A2 (en) | 2008-06-27 | 2010-01-28 | Otonomy, Inc. | Controlled-release cns modulating compositions and methods for the treatment of otic disorders |
US8349353B2 (en) | 2008-06-27 | 2013-01-08 | Otonomy, Inc. | Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders |
AU2009271129B2 (en) * | 2008-07-14 | 2013-10-10 | Otonomy, Inc. | Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
US20100016450A1 (en) * | 2008-07-21 | 2010-01-21 | Otonomy, Inc. | Controlled release delivery devices for the treatment of otic disorders |
US8399018B2 (en) * | 2008-07-21 | 2013-03-19 | Otonomy, Inc. | Controlled release ion channel modulator compositions and methods for the treatment of otic disorders |
US8496957B2 (en) | 2008-07-21 | 2013-07-30 | Otonomy, Inc | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
JP5421366B2 (en) * | 2008-07-21 | 2014-02-19 | オトノミ―,インク. | Controlled release otic structure modulating and innate immune system modulating compounds and methods for treatment of otic disorders |
CN102112112A (en) * | 2008-07-21 | 2011-06-29 | 奥德纳米有限公司 | Controlled release antimicrobial compositions and methods for treatment of otic disorders |
US8459310B2 (en) * | 2008-07-24 | 2013-06-11 | Surmodics, Inc. | Systems and methods for filling medical device lumen |
AU2009307825A1 (en) | 2008-10-22 | 2010-04-29 | Rick FRIEDMAN | Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
WO2011049954A2 (en) * | 2009-10-21 | 2011-04-28 | Otonomy, Inc. | Compositions comprising wnt modulators or neurotoxins for the treatment of otic disorders |
ES2862673T3 (en) | 2011-12-12 | 2021-10-07 | Zilentin AG | Treatment of tinnitus by modulating the NKCC1 chloride cotransporter in the auditory system |
JP2015511242A (en) * | 2012-02-23 | 2015-04-16 | インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラリシェルシェ メディカル) | Calcineurin inhibitors for use in the treatment of pathological vestibular disorders |
EP2819741B1 (en) * | 2012-02-27 | 2018-03-28 | O-Ray Pharma, Inc. | Solid drug implants for intracochlear delivery of therapeutics for the treatment of otic disorders |
WO2013178763A1 (en) * | 2012-05-30 | 2013-12-05 | Sensorion | Methods for treating vestibulotoxicity |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
MX351261B (en) | 2012-06-01 | 2017-10-06 | Surmodics Inc | Apparatus and method for coating balloon catheters. |
WO2014031676A1 (en) * | 2012-08-20 | 2014-02-27 | O-Ray Pharma, Inc. | Process for manufacturing drug delivery formulations |
US11090468B2 (en) | 2012-10-25 | 2021-08-17 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US10213564B2 (en) | 2014-05-19 | 2019-02-26 | Frank J. Cain | Biomedical aural delivery systems and methods |
PT3297628T (en) * | 2015-05-18 | 2021-08-16 | Sensorion | Calcineurin inhibitors of the setron family for the treatment of hearing loss |
US11612605B2 (en) * | 2016-04-14 | 2023-03-28 | Sensorion | (+)-azasetron for use in the treatment of ear disorders |
BR112018071123A2 (en) * | 2016-04-14 | 2019-02-05 | Sensorion | (+) - azasetron for use in treating ear disorders |
US11040004B2 (en) | 2016-09-16 | 2021-06-22 | Otonomy, Inc. | Otic gel formulations for treating otitis externa |
AU2019256527A1 (en) | 2018-04-19 | 2020-11-12 | Spiral Therapeutics, Inc. | Inner ear drug delivery devices and methods of use |
US11628466B2 (en) | 2018-11-29 | 2023-04-18 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
WO2020123312A1 (en) | 2018-12-09 | 2020-06-18 | Weinberg Assa | Method to prevent and treat macular degeneration by vasodilators |
WO2020142290A1 (en) * | 2018-12-30 | 2020-07-09 | Weinberg Assa | Method to prevent and treat hearing loss by calcium method to prevent and treat hearing loss |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2533004A (en) * | 1943-10-27 | 1950-12-05 | John D Ferry | Fibrin clots and methods for preparing the same |
US3520949A (en) * | 1966-07-26 | 1970-07-21 | Nat Patent Dev Corp | Hydrophilic polymers,articles and methods of making same |
US3896819A (en) * | 1969-04-01 | 1975-07-29 | Alejandro Zaffaroni | IUD having a replenishing drug reservoir |
GB1359614A (en) * | 1971-04-06 | 1974-07-10 | Dev Et De Rech Soc Fr De | Method for the manufacture of effervescent tablets |
IL47468A (en) * | 1975-06-12 | 1979-05-31 | Rehovot Res Prod | Process for the cross-linking of proteins using water soluble cross-linking agents |
US4368134A (en) * | 1980-03-10 | 1983-01-11 | Colgate Palmolive Company | Method for retarding gelation of bicarbonate-carbonate-zeolite-silicate crutcher slurries |
AT366916B (en) * | 1980-04-02 | 1982-05-25 | Immuno Ag | DEVICE FOR APPLICATING A TISSUE ADHESIVE BASED ON HUMAN OR ANIMAL PROTEINS |
US4565784A (en) * | 1981-01-26 | 1986-01-21 | Trustees Of Boston University | Hydrogels capable of supporting cell growth |
AT379311B (en) * | 1984-03-29 | 1985-12-27 | Immuno Ag | DEVICE FOR APPLICATING A TISSUE ADHESIVE |
US4601286A (en) * | 1984-04-20 | 1986-07-22 | Kaufman Jack W | Article for the protection of living tissues |
US4819647A (en) * | 1984-05-03 | 1989-04-11 | The Regents Of The University Of California | Intracochlear electrode array |
AT382783B (en) * | 1985-06-20 | 1987-04-10 | Immuno Ag | DEVICE FOR APPLICATING A TISSUE ADHESIVE |
US4646730A (en) * | 1986-05-23 | 1987-03-03 | Johnson & Johnson Products, Inc. | Color stabilized hydrogel dressing and process |
DE3722904A1 (en) * | 1987-01-09 | 1988-07-21 | Harald Maslanka | INJECTION DEVICE WITH DOUBLE CANNULA FOR AN ENDOSCOPE |
US4937270A (en) * | 1987-09-18 | 1990-06-26 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
US4978336A (en) * | 1987-09-29 | 1990-12-18 | Hemaedics, Inc. | Biological syringe system |
US4874368A (en) * | 1988-07-25 | 1989-10-17 | Micromedics, Inc. | Fibrin glue delivery system |
US4902281A (en) * | 1988-08-16 | 1990-02-20 | Corus Medical Corporation | Fibrinogen dispensing kit |
US5041292A (en) * | 1988-08-31 | 1991-08-20 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US5936035A (en) * | 1988-11-21 | 1999-08-10 | Cohesion Technologies, Inc. | Biocompatible adhesive compositions |
US5614587A (en) * | 1988-11-21 | 1997-03-25 | Collagen Corporation | Collagen-based bioadhesive compositions |
US5475052A (en) * | 1988-11-21 | 1995-12-12 | Collagen Corporation | Collagen-synthetic polymer matrices prepared using a multiple step reaction |
US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
US5304595A (en) * | 1988-11-21 | 1994-04-19 | Collagen Corporation | Collagen-polymer conjugates |
US5800541A (en) * | 1988-11-21 | 1998-09-01 | Collagen Corporation | Collagen-synthetic polymer matrices prepared using a multiple step reaction |
US5643464A (en) * | 1988-11-21 | 1997-07-01 | Collagen Corporation | Process for preparing a sterile, dry crosslinking agent |
US5527856A (en) * | 1988-11-21 | 1996-06-18 | Collagen Corporation | Method of preparing crosslinked biomaterial compositions for use in tissue augmentation |
US5550187A (en) * | 1988-11-21 | 1996-08-27 | Collagen Corporation | Method of preparing crosslinked biomaterial compositions for use in tissue augmentation |
US5226877A (en) * | 1989-06-23 | 1993-07-13 | Epstein Gordon H | Method and apparatus for preparing fibrinogen adhesive from whole blood |
US5104909A (en) * | 1989-09-21 | 1992-04-14 | W. R. Grace & Co.-Conn. | Water-absorbent, high capacity polyurethane foams |
US5116315A (en) * | 1989-10-03 | 1992-05-26 | Hemaedics, Inc. | Biological syringe system |
US5318524A (en) * | 1990-01-03 | 1994-06-07 | Cryolife, Inc. | Fibrin sealant delivery kit |
US5030215A (en) * | 1990-01-03 | 1991-07-09 | Cryolife, Inc. | Preparation of fibrinogen/factor XIII precipitate |
US5246698A (en) * | 1990-07-09 | 1993-09-21 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
US5391183A (en) * | 1990-09-21 | 1995-02-21 | Datascope Investment Corp | Device and method sealing puncture wounds |
US5529914A (en) * | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
US5626863A (en) * | 1992-02-28 | 1997-05-06 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5410016A (en) * | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5143662A (en) * | 1991-02-12 | 1992-09-01 | United States Surgical Corporation | Process for preparing particles of bioabsorbable polymer |
GB9111130D0 (en) * | 1991-05-23 | 1991-07-17 | Ici Plc | Azole derivatives |
US5296518A (en) * | 1991-05-24 | 1994-03-22 | Hampshire Chemical Corp. | Hydrophilic polyurethaneurea foams containing no toxic leachable additives and method to produce such foams |
US5368563A (en) * | 1991-12-18 | 1994-11-29 | Micromedics, Inc. | Sprayer assembly for physiologic glue |
US5192743A (en) * | 1992-01-16 | 1993-03-09 | Genentech, Inc. | Reconstitutable lyophilized protein formulation |
US5573934A (en) * | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
CA2117588C (en) * | 1992-02-28 | 1998-08-25 | Jeffrey A. Hubbell | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5514379A (en) * | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
AU675252B2 (en) * | 1992-12-18 | 1997-01-30 | Tremco, Inc. | Fast-curing, high strength, two-part sealants using acetoacetate-amine cure chemistry |
US5395923A (en) * | 1993-02-23 | 1995-03-07 | Haemacure-Biotech, Inc. | Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out" |
US5749968A (en) * | 1993-03-01 | 1998-05-12 | Focal, Inc. | Device for priming for improved adherence of gels to substrates |
ZA941881B (en) * | 1993-04-02 | 1995-09-18 | Lilly Co Eli | Manifold medication injection apparatus and method |
US5773025A (en) * | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
US5421818A (en) * | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
DE4402380A1 (en) * | 1994-01-27 | 1995-08-03 | Hans Peter Prof Dr Med Zenner | Implantable dosing system |
US6051576A (en) * | 1994-01-28 | 2000-04-18 | University Of Kentucky Research Foundation | Means to achieve sustained release of synergistic drugs by conjugation |
CA2140053C (en) * | 1994-02-09 | 2000-04-04 | Joel S. Rosenblatt | Collagen-based injectable drug delivery system and its use |
US5474540A (en) * | 1994-03-25 | 1995-12-12 | Micromedics, Inc. | Fluid separation control attachment for physiologic glue applicator |
US5672622A (en) * | 1994-04-21 | 1997-09-30 | Berlex Laboratories, Inc. | Treatment of multiple sclerosis |
KR0141431B1 (en) * | 1994-05-17 | 1998-07-01 | 김상웅 | Biodegradable hydrogel copolymer |
US5629384A (en) * | 1994-05-17 | 1997-05-13 | Consiglio Nazionale Delle Ricerche | Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces |
US5419491A (en) * | 1994-05-23 | 1995-05-30 | Mattson Spray Equipment, Inc. | Two component fluid spray gun and method |
DK0788351T3 (en) * | 1994-11-10 | 2003-05-26 | Univ Kentucky Res Found | Implantable, refillable device for speed-controlled drug delivery directly to an internal part of the body |
US5605541A (en) * | 1994-12-07 | 1997-02-25 | E. R. Squibb And Sons, Inc. | Fibrin sealant applicatoor |
US5810885A (en) * | 1994-12-28 | 1998-09-22 | Omrix Biopharm Sa | Device for applying one or several fluids |
US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
US5962023A (en) * | 1995-03-06 | 1999-10-05 | Ethicon, Inc. | Hydrogels containing absorbable polyoxaamides |
US5900245A (en) * | 1996-03-22 | 1999-05-04 | Focal, Inc. | Compliant tissue sealants |
US5656035A (en) * | 1995-04-25 | 1997-08-12 | Avoy; Donald R. | Refillable fibrinogen dispensing kit |
WO1996041818A1 (en) * | 1995-06-09 | 1996-12-27 | Drohan William N | Chitin hydrogels, methods of their production and use |
EP0842209B1 (en) * | 1995-07-28 | 2006-10-11 | Genzyme Corporation | Multiblock biodegradable hydrogels for use as controlled release agents for drugs and tissue treatment agents |
EP0876165B1 (en) * | 1995-12-18 | 2006-06-21 | Angiotech BioMaterials Corp. | Crosslinked polymer compositions and methods for their use |
US6214966B1 (en) * | 1996-09-26 | 2001-04-10 | Shearwater Corporation | Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution |
US5863551A (en) * | 1996-10-16 | 1999-01-26 | Organogel Canada Ltee | Implantable polymer hydrogel for therapeutic uses |
US6156728A (en) * | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
US6258351B1 (en) * | 1996-11-06 | 2001-07-10 | Shearwater Corporation | Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels |
US6271278B1 (en) * | 1997-05-13 | 2001-08-07 | Purdue Research Foundation | Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties |
US6045528A (en) * | 1997-06-13 | 2000-04-04 | Intraear, Inc. | Inner ear fluid transfer and diagnostic system |
US5906997A (en) * | 1997-06-17 | 1999-05-25 | Fzio Med, Inc. | Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions |
CA2305349A1 (en) * | 1997-10-27 | 1999-05-06 | Alexander R. Irvine | Methods and pharmaceutical compositions for the closure of retinal breaks |
US6306168B1 (en) * | 1998-05-04 | 2001-10-23 | Epic Biosonics Inc. | Means for implanting a device in the canalis cochlearis |
DE19853299C2 (en) * | 1998-11-19 | 2003-04-03 | Thomas Lenarz | Catheter for the application of medication in fluid spaces of the human inner ear |
US6110484A (en) * | 1998-11-24 | 2000-08-29 | Cohesion Technologies, Inc. | Collagen-polymer matrices with differential biodegradability |
US6093417A (en) * | 1999-01-11 | 2000-07-25 | Advanced Medical Instruments | Composition to treat ear disorders |
US6265379B1 (en) * | 1999-10-13 | 2001-07-24 | Allergan Sales, Inc. | Method for treating otic disorders |
US6375972B1 (en) * | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US6589286B1 (en) * | 2001-09-12 | 2003-07-08 | Jason Litner | Eustachian tube stent |
-
2003
- 2003-02-24 WO PCT/US2003/005519 patent/WO2003071986A2/en not_active Application Discontinuation
- 2003-02-24 US US10/372,636 patent/US20030229333A1/en not_active Abandoned
- 2003-02-24 AU AU2003216379A patent/AU2003216379A1/en not_active Abandoned
-
2007
- 2007-02-23 US US11/710,045 patent/US20070160648A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9132087B2 (en) | 2008-04-21 | 2015-09-15 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
US9205048B2 (en) | 2008-07-21 | 2015-12-08 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
US9233068B2 (en) | 2008-07-21 | 2016-01-12 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders |
US9427472B2 (en) | 2008-07-21 | 2016-08-30 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
US9486405B2 (en) | 2013-08-27 | 2016-11-08 | Otonomy, Inc. | Methods for the treatment of pediatric otic disorders |
Also Published As
Publication number | Publication date |
---|---|
US20070160648A1 (en) | 2007-07-12 |
WO2003071986A2 (en) | 2003-09-04 |
US20030229333A1 (en) | 2003-12-11 |
AU2003216379A1 (en) | 2003-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003071986A3 (en) | Method for treating otic disorders | |
EP2407203A3 (en) | Solid therapeutic agent for use in an implantable drug delivery device | |
WO2006035434A3 (en) | Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases | |
WO2007023408A3 (en) | 4d image-based planning methods and apparatus for targeted therapy | |
WO1997034586A3 (en) | Device and method for treating ophthalmic diseases | |
EP2248527A3 (en) | Compositions and methods for the control, prevention, and treatment of obesity and eating disorders | |
IL188789A0 (en) | Formulation and method for administration of ophthalmologically active agents | |
EP1633368A4 (en) | Foamable pharmaceutical compositions and methods for treating a disorder | |
EP2266539A3 (en) | Methods of treatment using a gastric retained gabapentin dosage | |
WO2007078922A3 (en) | Micronized device for the delivery of biologically active molecules and methods of use thereof | |
WO2004043480A3 (en) | Intraocular administration of cyclosporin a for the treatment of macular degeneration, retinopathy or retinitis pigmentosa | |
WO2005066337A3 (en) | Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation | |
IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
WO2005099667A3 (en) | Drug delivery compositions | |
WO2006047291A3 (en) | Spinal cord stimulation to treat auditory dysfunction | |
AU2003273182A1 (en) | Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases | |
HK1098960A1 (en) | Method and composition for treating rhinitis | |
WO2002094196A3 (en) | Method of treatment for cancers associated with elevated | |
WO2004066983A3 (en) | Controlled release of highly soluble agents | |
WO2004034889A3 (en) | Photodynamic therapy for ocular neovascularization | |
WO2004071432A3 (en) | Method for treating hypothyroidism | |
WO2004103985A3 (en) | Derivatives of fusarochromanone as therapeutic agents | |
WO2007019378A3 (en) | Method of treating neurological disorders | |
WO2004100899A3 (en) | Use of secretin in treatments of disorders associated with the amygdala | |
WO2005011589A3 (en) | Drug delivery methods and devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |